Background Obese subjects with chronic hepatitis C virus (HCV) infection have more rapidly progressive liver disease.
Objective In this study, we aimed to compare the hepatic cytokine and chemokine profiles in obese and lean subjects with chronic HCV infection using qRT-PCR and immunohistochemistry.
Methods Liver biopsies from 55 subjects were studied, including 20 with chronic hepatitis C, 25 with non-alcoholic fatty liver disease and 10 subjects with non-diseased liver.
Results Compared to the control groups, the liver injury in chronic hepatitis C was characterised by increased expression of several T-helper-1 cytokines including interferon-γ and tumour necrosis factor-α, and chemokines such as RANTES, IP-10 and MCP-1. In particular, in comparison with lean (BMI ≤25 kg/m2) HCV infected subjects, obese (BMI≥30 kg/m2) HCV infected subjects had increased hepatic expression of interferon-γ (p=0.004) and tumour necrosis factor-α (p<0.001), as well as increased expression of IP-10 (p=0.009) and MCP-1 (p<0.001). Localisation of these inflammatory chemokines revealed that in comparison to lean-HCV subjects, HCV infected liver from obese subjects exhibited significantly increased expression of IP-10 (p<0.001) and MCP-1 (p=0.02) in the inflammatory infiltrate of the portal tracts. In parallel, there was increased CD3 infiltration in the liver of obese-HCV subjects.
Conclusions The data provide important mechanistic information on the cause of hepatic injury in obese-HCV subjects including: (1) enhanced T helper-1 cytokine response patterns—to promote hepatocellular injury; (2) increased expression of the chemokines IP-10 and MCP-1 at both the mRNA and protein levels—to enhance inflammatory cell recruitment; (3) differing localisation of these chemokines within the liver of obese-HCV versus lean-HCV subjects—implying different inducing stimuli and; (4) increased CD3 expression in the liver of obese-HCV subjects—concordant with the increased expression of T cell chemoattractants.
- Hepatitis C virus
- TH-1 cytokines
- liver inflammation
Statistics from Altmetric.com
Competing interests None.
Ethics approval This study was conducted with the approval of the St George Hospital in Sydney, Australia.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.